Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Variant of BPIFB4 protein

A protein variant and protein technology, applied in the field of BPIFB4 protein variants, can solve problems such as loss of protein activity

Active Publication Date: 2015-09-30
LGV1 SRL
View PDF5 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These biological properties depend on the presence of four specific amino acids at positions 229, 281, 488, and 494 in the protein, because substitutions at any of these positions with different amino acids result in loss of protein activity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Variant of BPIFB4 protein
  • Variant of BPIFB4 protein
  • Variant of BPIFB4 protein

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0058] Example 1: Identification of the VTFThBPIFB4 protein in three independent populations

[0059] A recently published Genome Wide Association Study (GWAS) of Southern Italian Centenarians (SIC) has identified several genetic variants associated with longevity in individuals (Malovini et al., Rejuvenation Research 2011; 14(3), pp. 283-291).

[0060] To confirm the first 4 changes reported in this study (p-4 ), replicated in the first replication cohort recruited for the German Centenary Study (Keidorp et al; Aging Cell 2011; Vol. 10, pp. 622-8), The first replicate cohort comprised 1447 long-lived individuals (LLI) (age range 95 to 110 years, mean age 98.8 years) and 1029 younger controls (age range 60 to 75 years, mean age was 66.8 years). As a result, two non-synonymous single-nucleotide polymorphisms (single-nucleotide polymorphism, SNP) rs2070325 and rs571391 and two intron markers rs7583529 and rs285097 have been tested by Taqman analysis, the two intron Markers ...

Embodiment 2

[0072] Example 2: Haplotyping of the BPIFB4 locus

[0073] Haplotype analysis revealed a strong linkage disequilibrium (LD) pattern in the BPIFB4 genomic locus, which defined regions highly enriched in non-synonymous SNPs (Fig. S1 in the Supplementary Appendix). The rs2070325 variant (Ile229Val) of BPIFB4 tags rs2889732 (Asn288Thr), rs11699009 (Leu488Phe) and rs11696307 (Ile494Thr).

[0074] Through homology modeling with the I-TASSER program (REF: Ambrish Roy, Alper Kucukural, Yang Zhang. I-TASSER: a unified platform for automated protein structure and function prediction. Nature Protocols, Vol. 5, 725-738 (2010) .) and used the protein BPI (code 1EWF) from the PDB as a template to predict the three-dimensional structure of human BPIFB4. All models were considered in the visual structure analysis with the program PyMOL version 1.2r3pre, LLC (Molecular Graphics System) to carry out. The above analysis revealed that both Ile268Val and Asn320Thr are located at putative pro...

Embodiment 3

[0076] Example 3: Reactivity of isolated blood vessels to INFT hBPIFB4 and VTFT hBPIFB4

[0077] To determine the effect of the specific BPIFB4 variants identified on vascular function, we studied ex vivo transfection with pRK5 vectors encoding VTFT hBPIFB4 or proteins that differ from VTFT hBPIFB4 in that they exhibit multiple substitutions for four relevant amino acids. The effect of transfecting mouse mesenteric blood vessels, the protein is: INFT hBPIFB4 having the amino acid sequence of SEQ ID NO: 3, which differs from VTFT hBPIFB4 in that it contains isoleucine at positions 229 and 281 and Asparagine; VNFT hBPIFB4 having the amino acid sequence of SEQ ID NO: 4, which differs from VTFT hBPIFB4 in that it contains asparagine at position 281; ITFT hBPIFB4 having the amino acid sequence of SEQ ID NO: 5, which differs from VTFT hBPIFB4 VTFT hBPIFB4 differs in that it contains isoleucine at position 229; VTLI hBPIFB4 having the amino acid sequence of SEQ ID NO: 6 differs fro...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to an variant of BPIFB4 (Bactericidal / Permeability Increasing protein family B, member 4) protein and its use for the treatment of pathologies involving impairment of nitric oxide signalling.

Description

technical field [0001] The present invention relates to variants of the BPIFB4 protein (bactericidal / permeability-increasing protein family B, member 4) and their use in the treatment of pathologies associated with impaired eNOS and endothelial dysfunction caused by NO-mediated vasodilation the use of. Background technique [0002] Human BPIFB4 (also known as C20orf186; RY2G5; LPLUNC4) is a secreted protein member of the BPI / LBP / PLUNC-like family that has been implicated in host defense processes against bacteria. This protein exists in two different isoforms of different lengths with amino acid sequences of 575 (Acc.P-59827-2) and 613 (Acc.EAW76337.1) amino acids (Bingle CD et al., Biochem Soc Trans. (2011) 39(4): 977-83; Andrault J.-B et al., Genomics (2003) 82: 172-184; Bingle C.D et al., Hum. Mol. Genet. (2002) 11: 937-943; Bingle C.D et al., Protein Sci . (2004) 13: 422-430). [0003] For this protein, several single nucleotide polymorphisms have been described at th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K14/47
CPCC07K14/4742C07K14/47A61K38/00A61P11/00A61P13/12A61P15/00A61P15/10A61P25/00A61P25/28A61P27/02A61P27/06A61P27/12A61P29/00A61P35/00A61P3/06A61P43/00A61P7/02A61P9/00A61P9/10A61P9/12A61P3/10A61K38/1751C12N15/86C12N2710/10343C12N2750/14143C07K2319/20C12N2015/8518C12N15/81
Inventor 安尼巴莱·亚历山德罗·普卡察尔米内·韦基奥内
Owner LGV1 SRL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products